The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study
Teitelbaum JE, Johnson C, St Cyr J
Published in Journal of Alternative and Complementary Medicine
Methodology
Open-label uncontrolled pilot in 41 patients with chronic fatigue syndrome or fibromyalgia given D-ribose 5 g three times daily for approximately 3 weeks.
Key Findings
Around two-thirds of participants reported improvement, with average increases in energy, sleep, mental clarity and wellbeing on self-report scales.
Conclusions
D-ribose was associated with self-reported symptom improvement, but the uncontrolled design cannot exclude placebo effects.
Limitations
No control group or blinding; subjective outcomes; manufacturer-funded.
Supplements Studied
Around two-thirds of participants reported improvement in energy, sleep and mental clarity.
Outcomes Measured
Participants reported average increases in energy and wellbeing on self-report scales.
Around two-thirds of participants reported improvement, with average increases in energy, sleep, mental clarity and wellbeing on self-report scales.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.